Funding for this research was provided by:
Foundation for the National Institutes of Health (1U54CA193489, R01CA187532, U01CA200464)
Received: 13 August 2021
Accepted: 22 November 2021
First Online: 15 December 2021
: The Institutional Review Board at the University of South Florida approved (IRB #20383) and waived the informed consent requirement for retrospective analysis in this study.
: Not applicable.
: RJG has a competing interest as investor with research support from HealthMyne, Inc. (not used in current study). SHE received research support from Varian Medical Systems and ViewRay Inc and honoraria from Merck & Co. SAR reports consulting honoraria from Novocure, and research support and consulting honoraria from Viewray Inc. Other authors declare no potential conflicts of interest.